| Accession | Title | Sample type | Organism(s) | Ch | Platform | Series | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|---|
 Filter
|
GSE210057
|
||||||||
| GSM6415744 |
WT Control treated primary tumour biol rep 1 [LB5-4_1]
|
SRA | 1 |
|
Alexander Swarbrick | Aug 01, 2022 | |||
| GSM6415745 |
WT Control treated primary tumour biol rep 2 [LB5-4_2]
|
SRA | 1 |
|
Alexander Swarbrick | Aug 01, 2022 | |||
| GSM6415746 |
WT Control treated primary tumour biol rep 3 [LB5-4_3]
|
SRA | 1 |
|
Alexander Swarbrick | Aug 01, 2022 | |||
| GSM6415747 |
WT IT treated primary tumour biol rep 1 [LB5-4_5]
|
SRA | 1 |
|
Alexander Swarbrick | Aug 01, 2022 | |||
| GSM6415748 |
WT IT treated primary tumour biol rep 2 [LB5-4_6]
|
SRA | 1 |
|
Alexander Swarbrick | Aug 01, 2022 | |||
| GSM6415749 |
WT Control treated primary tumour biol rep 1 [LB5-4_7]
|
SRA | 1 |
|
Alexander Swarbrick | Aug 01, 2022 | |||
| GSM6415750 |
WT Control treated primary tumour biol rep 2 [LB5-4_8]
|
SRA | 1 |
|
Alexander Swarbrick | Aug 01, 2022 | |||
| GSM6415751 |
WT Control treated primary tumour biol rep 3 [LB5-4_9]
|
SRA | 1 |
|
Alexander Swarbrick | Aug 01, 2022 | |||
| GSM6415752 |
WT IT treated mammary gland biol rep 3 [LB5-4_10]
|
SRA | 1 |
|
Alexander Swarbrick | Aug 01, 2022 | |||
| GSM6415753 |
WT IT treated primary tumour biol rep 4 [LB5-4_11]
|
SRA | 1 |
|
Alexander Swarbrick | Aug 01, 2022 | |||
| GSM6415754 |
WT IT treated primary tumour biol rep 5 [LB5-4_12]
|
SRA | 1 |
|
Alexander Swarbrick | Aug 01, 2022 | |||
| GSM6415755 |
NSG primary tumour biol rep 1 [LB5-4_SJ13]
|
SRA | 1 |
|
Alexander Swarbrick | Aug 01, 2022 | |||
| GSM6415756 |
NSG primary tumour biol rep 2 [LB5-4_SJ14]
|
SRA | 1 |
|
Alexander Swarbrick | Aug 01, 2022 | |||
| GSM6415757 |
NSG primary tumour biol rep 3 [LB5-4_SJ15]
|
SRA | 1 |
|
Alexander Swarbrick | Aug 01, 2022 | |||
| GSM6415758 |
NSG primary tumour biol rep 4 [LB5-4_SJ16]
|
SRA | 1 |
|
Alexander Swarbrick | Aug 01, 2022 | |||
| GSM6415759 |
NSG primary tumour biol rep 5 [LB5-4_SJ17]
|
SRA | 1 |
|
Alexander Swarbrick | Aug 01, 2022 | |||
| GSM6415760 |
NSG primary tumour biol rep 6 [LB5-4_SJ18]
|
SRA | 1 |
|
Alexander Swarbrick | Aug 01, 2022 | |||
| GSM6415761 |
Cell pellet [LB5-4_SJ19]
|
SRA | 1 |
|
Alexander Swarbrick | Aug 01, 2022 | |||
| GSM6415762 |
primary tumour CD8 depleted [SJ66-PT-44534]
|
SRA | 1 |
|
Alexander Swarbrick | Aug 01, 2022 | |||
| GSM6415763 |
primary tumour control [SJ66-PT-44535]
|
SRA | 1 |
|
Alexander Swarbrick | Aug 01, 2022 |
